Table of Contents

June 1, 2024; Volume 65,Issue 6

  1. Maiti, Baijayanta

    1. PET Quantification of [<sup>18</sup>F]VAT in Human Brain and Its Test–Retest Reproducibility and Age Dependence
      PET Quantification of [18F]VAT in Human Brain and Its Test–Retest Reproducibility and Age Dependence
      John L. O’Donnell, Anil Kumar Soda, Hao Jiang, Scott A. Norris, Baijayanta Maiti, Morvarid Karimi, Meghan C. Campbell, Stephen M. Moerlein, Zhude Tu and Joel S. Perlmutter
      Journal of Nuclear Medicine June 1, 2024, 65 (6) 956-961; DOI: https://doi.org/10.2967/jnumed.123.266860

  2. Mankoff, David A.

    1. [18F]Fluoroestradiol Uptake in Irradiated Lung Parenchyma and Draining Nodes
      Audrey A. Rich, Neil K. Taunk, David A. Mankoff, Austin R. Pantel and Sophia R. O’Brien
      Journal of Nuclear Medicine June 1, 2024, 65 (6) 990-991; DOI: https://doi.org/10.2967/jnumed.123.266511

  3. Marek, Ken

    1. Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [<sup>18</sup>F]PI-2620
      Open Access
      Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [18F]PI-2620
      Gérard N. Bischof, Matthias Brendel, Henryk Barthel, Hendrik Theis, Michael Barbe, Peter Bartenstein, Joseph Claasen, Adrian Danek, Günter Höglinger, Johannes Levin, Ken Marek, Bernd Neumaier, Carla Palleis, Marianne Patt, Michael Rullmann, Dorothee Saur, Matthias L. Schroeter, John Seibyl, Mengmeng Song, Andrew Stephens, Osama Sabri, Alexander Drzezga, Thilo van Eimeren and for the German Imaging Initiative for Tauopathies
      Journal of Nuclear Medicine June 1, 2024, 65 (6) 952-955; DOI: https://doi.org/10.2967/jnumed.123.265930

  4. Mavriopoulou, Eleni

    1. Diagnostic Potential of Supplemental Static and Dynamic <sup>68</sup>Ga-FAPI-46 PET for Primary <sup>18</sup>F-FDG–Negative Pulmonary Lesions
      Diagnostic Potential of Supplemental Static and Dynamic 68Ga-FAPI-46 PET for Primary 18F-FDG–Negative Pulmonary Lesions
      Manuel Röhrich, Johanna Daum, Ewgenija Gutjahr, Anna-Maria Spektor, Frederik M. Glatting, Yasemin Aylin Sahin, Hans Georg Buchholz, Jorge Hoppner, Cathrin Schroeter, Eleni Mavriopoulou, Kai Schlamp, Matthias Grott, Florian Eichhorn, Claus Peter Heußel, Hans Ulrich Kauczor, Michael Kreuter, Frederik Giesel, Mathias Schreckenberger, Hauke Winter and Uwe Haberkorn
      Journal of Nuclear Medicine June 1, 2024, 65 (6) 872-879; DOI: https://doi.org/10.2967/jnumed.123.267103

  5. Mavroeidi, Ilektra A.

    1. <sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy
      68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy
      Helena Lanzafame, Ilektra A. Mavroeidi, Kim M. Pabst, Mélanie Desaulniers, Marc Ingenwerth, Nader Hirmas, Lukas Kessler, Michael Nader, Timo Bartel, Stephan Leyser, Francesco Barbato, Martin Schuler, Sebastian Bauer, Jens T. Siveke, Ken Herrmann, Rainer Hamacher and Wolfgang P. Fendler
      Journal of Nuclear Medicine June 1, 2024, 65 (6) 880-887; DOI: https://doi.org/10.2967/jnumed.123.267248

  6. Meckel, Marian

    1. Safety and Efficacy of <em>Para</em>-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors
      Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors
      Alexandros Moraitis, Walter Jentzen, Pedro Fragoso Costa, David Kersting, Stephan Himmen, Marta Coelho, Marian Meckel, Cees J.A. van Echteld, Wolfgang P. Fendler, Ken Herrmann and Miriam Sraieb
      Journal of Nuclear Medicine June 1, 2024, 65 (6) 931-937; DOI: https://doi.org/10.2967/jnumed.123.266619

  7. Melisko, Michelle

    1. <sup>68</sup>Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with <sup>18</sup>F-FDG
      68Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with 18F-FDG
      Brad Kline, Surekha Yadav, Youngho Seo, Robin Cumming Ippisch, Jessa Castillo, Rahul R. Aggarwal, Robin Kate Kelley, Spencer C. Behr, Robert R. Flavell, Courtney Lawhn-Heath, Michelle Melisko, Hope S. Rugo, Victoria Wang, Sue S. Yom, Patrick Ha, Fei Jiang and Thomas A. Hope
      Journal of Nuclear Medicine June 1, 2024, 65 (6) 938-943; DOI: https://doi.org/10.2967/jnumed.123.267281

  8. Mertens, Laura S.

    1. A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers
      A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers
      Marinus J. Hagens, Pim J. van Leeuwen, Maurits Wondergem, Thierry N. Boellaard, Francesco Sanguedolce, Daniela E. Oprea-Lager, Axel Bex, André N. Vis, Henk G. van der Poel and Laura S. Mertens; in collaboration with the EAU Section of Urological Imaging
      Journal of Nuclear Medicine June 1, 2024, 65 (6) 888-896; DOI: https://doi.org/10.2967/jnumed.123.267260

  9. Metzenmacher, Martin

    1. Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in <em>EGFR</em>-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance
      Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance
      Martin Schuler, Jörg Hense, Kaid Darwiche, Sebastian Michels, Hubertus Hautzel, Carsten Kobe, Smiths Lueong, Martin Metzenmacher, Thomas Herold, Gregor Zaun, Katharina Laue, Alexander Drzezga, Dirk Theegarten, Felix Nensa, Jürgen Wolf, Ken Herrmann and Marcel Wiesweg
      Journal of Nuclear Medicine June 1, 2024, 65 (6) 851-855; DOI: https://doi.org/10.2967/jnumed.123.266979

  10. Michels, Sebastian

    1. Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in <em>EGFR</em>-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance
      Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance
      Martin Schuler, Jörg Hense, Kaid Darwiche, Sebastian Michels, Hubertus Hautzel, Carsten Kobe, Smiths Lueong, Martin Metzenmacher, Thomas Herold, Gregor Zaun, Katharina Laue, Alexander Drzezga, Dirk Theegarten, Felix Nensa, Jürgen Wolf, Ken Herrmann and Marcel Wiesweg
      Journal of Nuclear Medicine June 1, 2024, 65 (6) 851-855; DOI: https://doi.org/10.2967/jnumed.123.266979
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue